Frequency / statistic
Research frontier
1 supporting source
confidence 97%
novelty 60%
1 The worldwide prevalence of 17q12DS is unknown although one study reported this condition in 1 in 14,500 people in Ice
A source reports “1 in 14,500” in the context of general: “1 The worldwide prevalence of 17q12DS is unknown although one study reported this condition in 1 in 14,500 people in Iceland.”
How this was derived
Numbers are quoted verbatim from the source; check the source before quoting onward.
Generated 2026-11-13, last changed
today. Dedup key freq:1 in 14,500.
The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.
Evidence (3 quotes)
One study estimated that 17q12 deletion syndrome occurs in 1 in 14,500 people in Iceland.
A Case of 17q12 Microdeletion Syndrome in a MODY5 Type Diabetes with HNF-1β Gene Mutation Accompanied
peer_reviewed
· published 2024-01-01
· live page
Its incidence in the general population is around 1 in 14,500 and is linked with facial deformities, diabetes, polycystic kidneys, pancreatic hypertrophy, liver anomalies, and neuropsychological impairments.
Decreased T helper 1 cell function underlies recurrent sinopulmonary infections in the 17q12 deletion syndrome
peer_reviewed
· published 2025-01-01
· live page
1 The worldwide prevalence of 17q12DS is unknown although one study reported this condition in 1 in 14,500 people in Iceland.
Supporting documents (3)
| Article | Source | Published | Seen | Relevance |
|---|---|---|---|---|
| 17q12 deletion syndrome: MedlinePlus Genetics | web | - | today | 1.00 |
| A Case of 17q12 Microdeletion Syndrome in a MODY5 Type Diabetes wit... | pmc | 2024-01-01 | yesterday | 1.00 |
| Decreased T helper 1 cell function underlies recurrent sinopulmonar... | pmc | 2025-01-01 | yesterday | 1.00 |